Year: 2007
Type: article
Abstract: This issue of the Journal features two cohort studies which show a marked excess of schizophrenia in African Americans,1 and a dose–response relationship between perceived discrimination and excess rates of schizophrenia in different minority groups in The Netherlands.2 These studies mirror one another, and numerous other studies carried out in developed countries, in inferring that minority groups are at elevated risk for schizophrenia, and that social factors—particularly discrimination-related disadvantages—are partially responsible. That these elevated rates have been the subject of scientific investigations is fully justified—if the higher rate of schizophrenia in minority groups were ignored, we would feel rightly outraged. Likewise, we believe ignoring the mental health needs of other disadvantaged groups—for example, women or conflict-affected people—is both scientifically and morally indefensible. It is scientifically indefensible because these groups are particularly vulnerable to suffering from poor mental health. It is morally indefensible because in the context of other important disadvantages across multiple axes, attempting to understand and address mental health inequalities becomes still more pressing as a matter of social justice.3
DOI: 10.1093/ije/dym147
Authors: V. Patel, A. Goodman
Institution: London School of Hygiene & Tropical Medicine
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Wellcome Trust
OpenAlex ID: W2109205901
